Publication Information

{'id': 'https://openalex.org/W2367839196', 'doi': None, 'title': 'Atorvastatin of the Pharmacological Effects and Clinical Application', 'display_name': 'Atorvastatin of the Pharmacological Effects and Clinical Application', 'publication_year': 2012, 'publication_date': '2012-01-01', 'ids': {'openalex': 'https://openalex.org/W2367839196', 'mag': '2367839196'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-YYXK201225036.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764880362', 'display_name': 'Guide of China Medicine', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4361727486', 'host_organization_name': 'China Medical Science Foundation', 'host_organization_lineage': ['https://openalex.org/P4361727486'], 'host_organization_lineage_names': ['China Medical Science Foundation'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100405781', 'display_name': 'Ping Zhang', 'orcid': 'https://orcid.org/0000-0001-9163-6191'}, 'institutions': [{'id': 'https://openalex.org/I4210140629', 'display_name': 'Guizhou Magic Pharmaceutical (China)', 'ror': 'https://ror.org/035brg434', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210140629']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Zhang Ping', 'raw_affiliation_strings': ['1 Guizhou Province Pharmaceutical'], 'affiliations': [{'raw_affiliation_string': '1 Guizhou Province Pharmaceutical', 'institution_ids': ['https://openalex.org/I4210140629']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5100405781'], 'corresponding_institution_ids': ['https://openalex.org/I4210140629'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10394', 'display_name': 'Lipoproteins and Cardiovascular Health', 'score': 0.8922, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10394', 'display_name': 'Lipoproteins and Cardiovascular Health', 'score': 0.8922, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.861, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10211', 'display_name': 'Computational Drug Discovery Methods', 'score': 0.8255, 'subfield': {'id': 'https://openalex.org/subfields/1703', 'display_name': 'Computational Theory and Mathematics'}, 'field': {'id': 'https://openalex.org/fields/17', 'display_name': 'Computer Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/group-b', 'display_name': 'Group B', 'score': 0.6439363}, {'id': 'https://openalex.org/keywords/group-a', 'display_name': 'Group A', 'score': 0.49356186}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.97922754}, {'id': 'https://openalex.org/C2777482532', 'wikidata': 'https://www.wikidata.org/wiki/Q668093', 'display_name': 'Atorvastatin', 'level': 2, 'score': 0.9633928}, {'id': 'https://openalex.org/C2777785397', 'wikidata': 'https://www.wikidata.org/wiki/Q492194', 'display_name': 'Group B', 'level': 2, 'score': 0.6439363}, {'id': 'https://openalex.org/C2777698277', 'wikidata': 'https://www.wikidata.org/wiki/Q266018', 'display_name': 'Acute coronary syndrome', 'level': 3, 'score': 0.62418664}, {'id': 'https://openalex.org/C139572402', 'wikidata': 'https://www.wikidata.org/wiki/Q4927820', 'display_name': 'Blood lipids', 'level': 3, 'score': 0.57715535}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.5685667}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5061287}, {'id': 'https://openalex.org/C2780678043', 'wikidata': 'https://www.wikidata.org/wiki/Q743241', 'display_name': 'Group A', 'level': 2, 'score': 0.49356186}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.33609673}, {'id': 'https://openalex.org/C2778163477', 'wikidata': 'https://www.wikidata.org/wiki/Q43656', 'display_name': 'Cholesterol', 'level': 2, 'score': 0.12994742}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.12872961}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-YYXK201225036.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764880362', 'display_name': 'Guide of China Medicine', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4361727486', 'host_organization_name': 'China Medical Science Foundation', 'host_organization_lineage': ['https://openalex.org/P4361727486'], 'host_organization_lineage_names': ['China Medical Science Foundation'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.87, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2508111592', 'https://openalex.org/W2391806829', 'https://openalex.org/W2388424036', 'https://openalex.org/W2383224901', 'https://openalex.org/W2379304280', 'https://openalex.org/W2375702383', 'https://openalex.org/W2374003178', 'https://openalex.org/W2371281516', 'https://openalex.org/W2367290894', 'https://openalex.org/W2366378894', 'https://openalex.org/W2365677382', 'https://openalex.org/W2363697284', 'https://openalex.org/W2355392302', 'https://openalex.org/W2354552573', 'https://openalex.org/W2353418228', 'https://openalex.org/W2352648203', 'https://openalex.org/W2351292305', 'https://openalex.org/W2348165639', 'https://openalex.org/W2130668154', 'https://openalex.org/W1684316421'], 'abstract_inverted_index': {'Objective': [0], 'On': [1], 'atorvastatin': [2, 46], 'effect': [3, 107], 'of': [4, 7, 11, 24, 38, 79, 91], 'the': [5, 42, 50, 57], 'treatment': [6, 60], 'acute': [8, 27], 'coronary': [9, 28], 'syndrome,analysis': [10], 'its': [12], 'pharmacological': [13], 'effects.Methods': [14], 'Random': [15], 'selection': [16], 'in': [17, 20, 30, 41, 49, 56, 61, 88, 98], 'our': [18], 'hospital': [19], 'September': [21, 31], '2009-76': [22], 'cases': [23], 'patients': [25, 40, 64], 'with': [26, 65, 72], 'syndrome,admitted': [29], '2011,divided': [32], 'into': [33], 'two': [34], 'groups(A,B)': [35], 'A': [36, 63], 'group': [37, 62, 69, 84, 89], '43': [39], 'observation': [43], 'group,to': [44], 'give': [45], 'treatment;B': [47], '33patients': [48], 'control': [51], 'group,given': [52], 'Sylow': [53], 'cilostazol': [54], 'tablets': [55], 'treatment.Results': [58], 'After': [59], 'disease': [66], 'recovery': [67], 'than': [68, 83, 87, 96], 'B': [70, 99], 'patients,patients': [71], 'blood': [73, 105], 'lipid': [74, 106], 'levels': [75, 78], 'and': [76], 'serum': [77], 'inflammatory': [80], 'factors': [81], 'lower': [82, 95], 'B,treatment': [85], 'efficiency': [86], 'B,incidence': [90], 'adverse': [92], 'reactions': [93], 'was': [94], 'that': [97], 'group.Conclusion': [100], 'Atorvastatin': [101], 'for': [102], 'anti-inflammatory,to': [103], 'improve': [104], 'is': [108], 'better.': [109]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2367839196', 'counts_by_year': [], 'updated_date': '2024-12-14T11:41:38.020201', 'created_date': '2016-06-24'}